Lunit and Leica, PD-L1 AI solution launch and its impact on the industry
Lunit and Leica's AI-based PD-L1 biomarker solution, Lunit SCOPE PD-L1 CAL10, has been launched. During the same period, CoAsia CM began developing a depth camera for robotics, while a securities firm set a target price of 380 ten thousand won for SK hynix and a target price of 2 ten thousand won for Socar.
Get free 루닛 email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Lunit and Leica 5month 26day, AI-based PD-L1 biomarker solution, Lunit SCOPE PD-L1 CAL10, has been launched, the companies announced. The two companies described the product as the first outcome of their collaboration. According to the report, it was developed to support pathological diagnosis.
The solution was described as software that supports interpretation of the PD-L1 biomarker. The product name includes CAL10. The announcement reportedly included plans for commercialization and the scope of application.
CoAsia CM has begun developing a depth-camera solution for robotics. The company disclosed the start of development. The development is reportedly aimed at enabling robots to perceive distance.
A securities firm set SK hynix’s target price at 380ten-thousand won. The related report presented the figure based on the market outlook. The figure was provided as a reference for investment decisions.
Another securities firm raised its target price for SOCAR to 2ten-thousand won. The report cited expectations of improved earnings at SOCAR as the reason for the increase. The basis and assumptions for the increase were reportedly set out in the report.
These reports are examples of market issues involving medical AI, robotics components, semiconductors and mobility being raised at the same time. Each company’s announcements and securities firms’ reports were released separately in the form of disclosures and reports. Investors can check the original disclosures and reports.